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Comments on “Evidence-Based Behavioral Medicine:
What Is It and How Do We Achieve It?”: The Interventionist
Does Not Always Equal the Intervention—The Role of Therapist Competence
Arthur M. Nezu, Ph.D., ABPP and Christine Maguth Nezu, Ph.D., ABPP
Drexel University
Davidson et al. (1) provided the field of behavioral medi-
cine a significant and timely service by outlining “do’s and
don’ts” regarding the design and reporting of randomized clini-
cal trials (RCTs). Such a checklist helps researchers to guard
against threats to internal and external validity and can advance
evidence-based medicine by ultimately providing scientifically
sound data regarding the efficacy of various psychosocial inter-
vention strategies. Although these authors are to be commended
for the general breadth of these guidelines, we wish to take this
opportunity to expand on one issue that they noted, that of treat-
ment integrity, not because of any disagreement, but because we
believe they did not fully discuss the issue of the “therapist” as a
Type I error concern.
Treatment integrity, in the psychotherapy outcome litera-
ture, refers to two major issues regarding a given treatment arm
in an RCT—adherence and competence (2). Adherence refers to
the degree to which a provider conducted treatment according to
some external set of criteria, usually a therapy manual. Compe-
tence, although related, can greatly range in its degree of corre-
lation with adherence. In this context, competence involves the
degree to which the therapist conducts the treatment in a mini-
mally effective manner. Therapists, even if adherent, can range
in competence from incompetent (e.g., provider describes the
rationale for the treatment in a hurried or incomplete manner) to
expert (e.g., provider describes the treatment rationale compre-
hensively, in easily understood terms, and in a way that allows
patients to better understand how this treatment is relevant for
them). It is this range that represents the major threat to internal
validity. In drug trials, it is correctly assumed that if a given
pharmacological intervention is represented by accurate mea-
surement or “pill counting” (i.e., each unit of a drug is the same),
one can validly measure the impact of the drug. However, to as-
sume that “all therapists are equally competent” is to ignore a
potentially large degree of variance not accounted for by the
treatment per se. In other words, the intervention does not equal
the interventionist. As such, it becomes difficult to determine
whether treatment effects (or lack of) are due to the hypothe-
sized mechanism of action (i.e., the active ingredient within the
intervention) or the treatment provider (3).
Although the impact of therapist competency on treatment
outcome has only been recently addressed in a meaningful
manner (4), initial results suggest that higher levels of thera-
pist competency are significantly associated with improved
patient outcome (5,6). As such, it behooves all researchers
conducting RCTs that involve a psychosocial intervention in
the future both to incorporate procedures to methodologically
enhance therapist competence (e.g., detailed treatment manu-
als, use of “expert” providers, enhanced training protocols,
sustained supervision of providers) as well as methods to sys-
tematically assess both adherence and competence (e.g., sys-
tematic assessment of therapist behaviors via audio- or video-
tape of actual treatment) and to determine whether either
served to moderate outcome.
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